Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-20

Clinical Trial Update: A Phase 1 Study of TE-8214 Solution in Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 trial of TE-8214 Solution in healthy volunteers has completed. Acromegaly is listed as the condition of interest for the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TE-8214 Solution

Snippet

Sponsor: Immunwork, Inc. | Conditions: Acromegaly | Phase 1 | Status: COMPLETED